Epoch Biodesign, a U.K. startup, has secured $18.3 million in Series A funding to scale its production of enzymes that break down plastic waste. Founded in 2019, the company aims to transfer its biorecycling process from labs to a production facility capable of processing 150 tonnes of waste annually.

Epoch’s biorecycling platform unlocks circularity for the toughest-to-recycle materials. Our AI-designed enzymes enable infinite recycling for mixed plastics and textiles at low temperatures. We produce sustainable outputs for use in apparel, automotive, packaging and more.



www.epochbiodesign.com

Biotechnology

Epoch Biodesign raised $18.3M in Series A funding to scale up production of their plastic-eating enzymes.

Description

Company Information

Related People

Funding Insights

Epoch Biodesign raised $18.3M in Series A funding to scale up production of their plastic-eating enzymes.

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information